FDA Inspection 1044918 — Hillestad Pharmaceuticals USA, Inc.
The FDA completed an inspection of Hillestad Pharmaceuticals USA, Inc. on March 2, 2018 in Woodruff, WI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 2, 2018
- Fiscal Year
- 2018
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Woodruff, WI (United States)